Composition for the prevention or treatment of liver disease comprising a 12-LOX expression promoter

Liver disease composition based on a 12-LOX expression promoter that enhances the effect of docosahexaenoic acid

This technology relates to a composition for the prevention and treatment of liver disease, comprising 12-LOX or its expression promoter as an active ingredient, which enhances the effect of docosahexaenoic acid (DHA).

An auxiliary target was needed to fully maximize the beneficial effects of DHA on liver disease.

This technology confirmed that 12-LOX or its expression promoter significantly increases the liver disease improvement, prevention, and treatment effects of DHA, thus allowing it to be utilized as an effective composition for liver disease.

‍

‍

Key Features:

• Comprises 12-LOX or a 12-LOX expression promoter as an active ingredient
• Enhanced liver disease improvement effect of docosahexaenoic acid (DHA)
• Enhanced liver disease prevention and treatment effects
• Applicable as a functional material or pharmaceutical composition